Superna Life Sciences

Superna Life Sciences is a specialty pharmaceutical and biotechnology company headquartered in Hyderabad, India, that focuses on the development of complex generics and value-added medicines. The company utilizes advanced drug delivery platforms, including liposomes, nanoparticles, and microspheres, to enhance the therapeutic profile and safety of existing pharmaceutical agents. Their research efforts are primarily directed toward high-growth therapeutic segments such as oncology, central nervous system (CNS) disorders, and cardiovascular health. Superna operates a state-of-the-art R&D center and provides comprehensive contract research services, ranging from formulation development to analytical testing and regulatory support for global markets. The company leverages the 505(b)(2) regulatory pathway to bring innovative, improved versions of established drugs to the international market.